11C-flumazenil PET in neocortical epilepsy

Neurology

Volumn 51, Issue 2, 1998, Pages 485-492

  Richardson, M P ^a,b   Koepp, M J ^a,b   Brooks, D J ^b   Duncan, J S ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR; CARBON 11; FLUMAZENIL; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CARBON;

ADULT; ARTICLE; CLINICAL ARTICLE; EPILEPSY; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ADOLESCENT; BRAIN MAPPING; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FRONTAL LOBE EPILEPSY; HEMISPHERIC DOMINANCE; METABOLISM; METHODOLOGY; MIDDLE AGED; NEOCORTEX; PHYSIOLOGY; SCINTISCANNING; STATISTICAL MODEL;

ADOLESCENT; ADULT; BRAIN MAPPING; CARBON ISOTOPES; EPILEPSIES, PARTIAL; EPILEPSY, FRONTAL LOBE; FEMALE; FLUMAZENIL; FUNCTIONAL LATERALITY; GABA MODULATORS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOCORTEX; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031596322     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.2.485     Document Type: Article

References (34)

1. Spencer SS. MRI and epilepsy surgery. Neurology 1995;45: 1248-1250.
2. Duncan JS. Imaging and epilepsy. Brain 1997;120:376-389.
3. Cascino GD, Jack CR, Parisi JE, et al. MRI in the presurgical evaluation of patients with frontal lobe epilepsy and children with temporal lobe epilepsy: pathologic correlation and prognostic importance. Epilepsy Res 1992;11:51-59.
4. Henry TR, Sutherling WW, Engel J Jr, et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res 1991;10:174-182.
5. Engel J Jr, Henry TR, Swartz BE. Positron emission tomography in frontal lobe epilepsy. In: Jasper HH, Riggio S, Goldman-Rakic PS, eds. Epilepsy and the functional anatomy of the frontal lobe. New York: Raven Press, 1995:223-238.
6. Richards JG, Schoch P, Haring P, Takacs B, Mohler H. Resolving GABAA/benzodiazepine receptors: cellular and subcellular localization in the CNS with monoclonal antibodies. J Neurosci 1987;7:1866-1886.
7. Dichter MA, Ayala GF. Cellular mechanisms of epilepsy: a status report. Science 1987;237:157-164.
8. Loscher W. Basic aspects of epilepsy. Curr Opin Neurol 1993; 6:223-232.
9. Otis TS, De Koninck Y, Mody I. Lasting potentiation of inhibition is associated with an increased number of γ-aminobutyric acid type A receptors activated during miniature inhibitory postsynaptic currents. Proc Natl Acad Sci USA 1994;91:7698-7702.
10. Franck JE, Kunkel DD, Baskin DG, Schwartzkroin PA. Inhibition in kainate-lesioned hyperexcitable hippocampi: physiologic, autoradiographic, and immunocytochemical observations. J Neurosci 1988;8:1991-2002.
11. Craig CR, Colasanti BK. GABA receptors, lipids, and ganglio-sides in cobalt epileptic focus. Adv Neurol 1986;44:379-391.
12. Ribak CE, Hunt CA, Bakay RA, Oertel WH. A decrease in the number of GABAergic somata is associated with the preferential loss of GABAergic terminals at epileptic foci. Brain Res 1986;363:78-90.
13. Henry TR, Frey KA, Sackellares JC, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993;43:1998-2006.
14. 18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993;56:615-621.
15. Koepp MJ, Richardson MP, Brooks DJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis: an objective in vivo analysis. Brain 1996;119:1677-1687.
16. 11C]Flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 1995;36:1225-1232.
17. 11C-flumazenil PET study. Ann Neurol 1996;40: 188-198.
18. 11C]-flumazenil PET reveals central benzodiazepine receptor binding abnormalities in partial epilepsy with normal MRI. Neurology 1996;46:A122-A123. Abstract.
19. Spinks TJ, Jones T, Bailey DL, et al. Physical performance of a positron tomograph for brain imaging with retractable septa. Phys Med Biol 1992;37:1637-1655.
20. Bailey DL. 3D acquisition and reconstruction in positron emission tomography. Ann Nucl Med 1992;6:121-130.
21. Grootoonk S, Spinks TJ, Bloomfield PM, Sashin D, Jones T. The practical implementation and accuracy of dual window scatter correction in a neuroPET scanner with the septa retracted. IEEE Med Imaging Conference Records 1993;5:942-944.
22. 11C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. Int J Appl Radiat Isot 1984;35:973-976.
23. Ranicar ASO, Williams CW, Schnorr L, et al. The on-line monitoring of continuously withdrawn arterial blood during PET studies using a single BGO/photomultiplier assembly and non-stick tubing. Medical Progress Through Technology 1991;17:259-264.
24. 11C]Scherring 23390. J Label Compds and Radiopharm 1993;32:518-520.
25. 11C]deprenyl and dynamic positron emission tomography. J Cereb Blood Flow Metab 1991;11:545-556.
26. Robb RA, Hanson DP. A software system for interactive and quantitative visualization of multidimensional biomedical images. Austral Phys Eng Sci Med 1991;14:9-30.
27. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 1995;2:189-210.
28. Friston KJ, Ashburner J, Poline JB, et al. Spatial registration and normalization of images. Human Brain Mapping 1995;2: 165-189.
29. Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 1993;13:15-23.
30. Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [C-11] flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991;11:735-744.
31. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17: 536-546.
32. Friston KJ, Frith CD, Liddle PF, et al. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 1990;10:458-466.
33. Friston KJ, Worsley KJ, Frackowiak RSJ, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Human Brain Mapping 1994;1:214-220.
34. Palmini A, Andermann F, Olivier A, et al. Focal neuronal migration disorders and intractable partial epilepsy: a study of 30 patients. Ann Neurol 1991;30:741-749.